Increased Targeting Area in Tumors by Dual-Ligand Modification of Liposomes with RGD and TAT Peptides
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased Targeting Area in Tumors by Dual-Ligand Modification of Liposomes with RGD and TAT Peptides
Authors
Keywords
-
Journal
Pharmaceutics
Volume 14, Issue 2, Pages 458
Publisher
MDPI AG
Online
2022-02-22
DOI
10.3390/pharmaceutics14020458
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application
- (2021) Jun Wu Journal of Personalized Medicine
- An adapted dorsal skinfold model used for 4D intravital followed by whole-mount imaging to reveal endothelial cell–pericyte association
- (2021) Ann L. B. Seynhaeve et al. Scientific Reports
- In Vitro and In Vivo characterization of CPP and transferrin modified liposomes encapsulating pDNA
- (2020) Bruna dos Santos Rodrigues et al. Nanomedicine-Nanotechnology Biology and Medicine
- Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
- (2020) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Improved efficacy of doxorubicin delivery by a novel dual-ligand-modified liposome in hepatocellular carcinoma
- (2020) Xiaocheng Li et al. CANCER LETTERS
- Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma
- (2019) Sushant Lakkadwala et al. JOURNAL OF CONTROLLED RELEASE
- Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy
- (2019) Ping-Hsiu Wu et al. Cancers
- Tumor targeting via EPR: Strategies to enhance patient responses
- (2018) Susanne K. Golombek et al. ADVANCED DRUG DELIVERY REVIEWS
- Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer
- (2018) Pranali Deshpande et al. DRUG DELIVERY
- Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
- (2018) Lisa Belfiore et al. JOURNAL OF CONTROLLED RELEASE
- Liposomology: delivering the message
- (2018) Gregory Gregoriadis JOURNAL OF LIPOSOME RESEARCH
- Dual-targeted nanomedicines for enhanced tumor treatment
- (2018) Yaqin Zhu et al. Nano Today
- Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells
- (2018) Mohamadreza Amin et al. International Journal of Nanomedicine
- Cancer nanomedicine: is targeting our target?
- (2016) Twan Lammers et al. Nature Reviews Materials
- Dual ligand immunoliposomes for drug delivery to the brain
- (2015) Joana A. Loureiro et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region
- (2015) Mohamadreza Amin et al. JOURNAL OF CONTROLLED RELEASE
- Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG
- (2014) Ling Mei et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
- (2014) Hisataka Kobayashi et al. Theranostics
- Cell-penetrating peptides: 20 years later, where do we stand?
- (2013) Chérine Bechara et al. FEBS LETTERS
- Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT
- (2013) Jie Tang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas
- (2013) Mohamadreza Amin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery
- (2013) Feihu Wang et al. JOURNAL OF CONTROLLED RELEASE
- Enhanced Active Targeting via Cooperative Binding of Ligands on Liposomes to Target Receptors
- (2013) Tomoki Sugiyama et al. PLoS One
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Vascular density and endothelial cell expression of integrin alpha v beta 3 and E-selectin in murine tumours
- (2012) Johanne Seguin et al. TUMOR BIOLOGY
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
- (2011) Carlos Mas-Moruno et al. Anti-Cancer Agents in Medicinal Chemistry
- Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery
- (2011) Golam Kibria et al. JOURNAL OF CONTROLLED RELEASE
- Dual-targeting of αvβ3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo
- (2011) Ewelina Kluza et al. JOURNAL OF CONTROLLED RELEASE
- Targeted Drug Delivery and Penetration Into Solid Tumors
- (2011) Angelo Corti et al. MEDICINAL RESEARCH REVIEWS
- MR angiogenesis imaging with Robo4- vs. αVβ3-targeted nanoparticles in a B16/F10 mouse melanoma model
- (2010) Kent S. Boles et al. FASEB JOURNAL
- The Pharmacokinetics of Cell-Penetrating Peptides
- (2010) Dikran Sarko et al. MOLECULAR PHARMACEUTICS
- Disterolphospholipids: Nonexchangeable Lipids and Their Application to Liposomal Drug Delivery
- (2009) Zhaohua Huang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
- (2009) Antoinette Hollestelle et al. BREAST CANCER RESEARCH AND TREATMENT
- A novel DDS strategy, “dual-targeting”, and its application for antineovascular therapy
- (2009) Yuki Murase et al. CANCER LETTERS
- Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals
- (2009) Xue Ying et al. JOURNAL OF CONTROLLED RELEASE
- Sterol-Modified Phospholipids: Cholesterol and Phospholipid Chimeras with Improved Biomembrane Properties
- (2008) Zhaohua Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search